News
Symptoms, and Treatment Liver cancer is one of the most challenging forms of cancer, often developing quietly before showing any clear signs. It begins when abnormal cells form in the liver, a vital ...
Hepatocellular carcinoma (HCC), the most common form of liver cancer, continues to pose a significant global health challenge due to its high ...
6d
Sportschosun on MSNImmune anticancer drug treatment failure Progressive hepatocellular carcinoma improves survival rate with classical treatmentTwo international academic journals have found that it is effective to apply classical treatments to patients with advanced ...
EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation ...
4d
News Medical on MSNSerum hsa_circ_101555 as a promising biomarker for hepatocellular carcinomaHepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive diagnostic/prognostic biomarkers for early detection of HCC are still lacking.
3h
News Medical on MSNHumanized antibody dismantles metabolic barrier as a potential cancer immunotherapyA Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.
During a Community Case Forum event, Stacey Stein, MD, discussed data guiding the use of current regimens for the treatment ...
Cervical cancer was once the most common cancer in females but liver cancer is catching up and could soon be the second most ...
Agenus Inc. (Nasdaq: AGEN), a clinical-stage immuno-oncology company, today announced updated data from the hepatocellular carcinoma (HCC) cohort of its ongoing Phase 1 study evaluating botensilimab ...
Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results